DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Cinacalcet Hydrochloride is a drug marketed by Accord Hlthcare, Acme Labs, Alkem Labs Ltd, Aurobindo Pharma Ltd, Cipla, Lupin Ltd, Mylan, Piramal Hlthcare Uk, Strides Pharma, Sun Pharm, and Watson Labs Teva. and is included in eleven NDAs.
The generic ingredient in CINACALCET HYDROCHLORIDE is cinacalcet hydrochloride. There are twenty-four drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the cinacalcet hydrochloride profile page.
A generic version of CINACALCET HYDROCHLORIDE was approved as cinacalcet hydrochloride by AUROBINDO PHARMA LTD on March 8th, 2018.
Summary for CINACALCET HYDROCHLORIDE
|Suppliers / Packagers:||16|
|Bulk Api Vendors:||82|
|Formulation / Manufacturing:||see details|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for CINACALCET HYDROCHLORIDE|
|DailyMed Link:||CINACALCET HYDROCHLORIDE at DailyMed|
Recent Clinical Trials for CINACALCET HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|VA Office of Research and Development||Phase 4|
|University of California, San Francisco||Phase 4|
|Kyowa Hakko Kirin Korea Co., Ltd.||Phase 3|